WASHINGTON (March 26, 2020) – The United States Senate just passed a $2 trillion stimulus bill in response to the coronavirus crisis in the United States. The legislation includes provisions to support hospitals, small businesses and distressed companies caught in the public health and economic fallout from the pandemic.
The following is a statement from Margarida Jorge, national campaign director for Lower Drug Prices Now:
“This package is a step towards helping Americans stay healthy and get back on their feet in the midst of the coronavirus crisis.
Instead, Drug Should Come With Affordability Guardrails
Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now
Washington, DC (March 24, 2020) — Yesterday the Trump Administration gave the drug corporation Gilead Sciences special monopoly protection on the promising COVID-19 treatment Remdesivir, giving them a green light to price gouge on a desperately needed treatment.
It’s especially outrageous considering the significant public investment taxpayers have made to the research and development of Remdesivir by the United States Army Medical Research Institute of Infectious Diseases and the Centers for Disease Control.
WASHINGTON (March 20, 2020) – Since the start of the coronavirus COVID-19 outbreak in the U.S. the Lower Drug Prices Now Coalition has been sounding the alarm about potential Big Pharma price gouging if President Trump and Health and Human Services Secretary Azar fail to enact price control measures that ensure affordability.
To listen to the press conference, click: Audio recording (speaking begins at 3:30 mark) of the press conference
(Des Moines, Iowa, March 18, 2020) — We hear a lot from national sources about the continuing needs, concerns and spread of the COVID-19 virus. Today we heard from real Iowans representing Iowa government, small business, healthcare, and senior communities about the effects in Iowa.
Washington (March 12, 2020) – President Trump announced a new pilot project to cap insulin costs at $35 a month for people with diabetes participating in Medicare Part D. However, the proposed initiative is voluntary for drug makers and insurers and includes no controls on prices or negotiating power.
Statement from Margarida Jorge, campaign director for Lower Drug Prices Now:
“This proposal does nothing to make drug corporations lower prices.
WASHINGTON, DC – On Thursday, March 5 at 1pm, the Lower Drug Prices Now (LDPN) coalition, representing millions of Americans angered by Big Pharma’s price-gouging, will join Sen. Chris Van Hollen, and Reps. Jan Schakowsky and Lloyd Doggett in demanding that President Trump and Secretary Azar guarantee that any coronavirus treatment or vaccine developed with taxpayer dollars be affordable for all.
The Lower Drug Prices Now coalition advocates for comprehensive drug pricing reform that prioritizes public health ahead of corporate profit particularly when it comes to medicines funded by taxpayer research.
WASHINGTON (March 3, 2020) – President Trump met with pharmaceutical corporate executives today about finding a vaccine and treatment for the COVID-19 coronavirus, which is approaching 90,000 infections worldwide and has killed six people in the United States.
Despite calls from dozens of lawmakers for the Trump administration to prevent Pharma companies from hiking up the cost of a potential vaccine, Health and Human Services Secretary Alex Azar, a former drug executive himself,
“Big Pharma rang in the new year with a gift to itself: higher prices and bigger profits on over 200 prescription drugs. Drug corporations are congratulating themselves for keeping most hikes under 10 percent, but let’s be clear: for most hard working Americans, the household budget isn’t growing by 10, or even five percent this year. The upshot? Another year of higher co-pays and out-pocket costs, and another year of having to choose between taking on debt or paying for drugs we need.
“President Trump’s proposal to import prescription drugs is a poor substitute for real reforms that would guarantee everyone affordable medicine and stop Big Pharma’s price gouging. Instead, Trump’s plan does nothing to fix our fundamentally flawed system. Drug corporations will continue to reap record profits and hike prices without any check on their power. Patients still won’t be able to get hundreds of widely used medicines. Taxpayers will continue to fund research and development, while pharmaceutical corporations will keep using those investment to boost profits at our expense.
Margarida Jorge and Frank Clemente
The newly passed House bill allowing Medicare negotiations on drug prices is a first step toward taming Big Pharma and broader corporate abuse.
Last week’s House vote to rein in skyrocketing prescription drug prices was overdue. Now it’s up to the Senate and President Donald Trump to take action.
Today’s bipartisan vote to pass the Elijah E. Cummings Lower Drug Prices Now Act is a critical step in helping more patients get the prescription drugs they need to be healthy. For the first time ever, this law would give the government the power to negotiate lower drug prices for millions of seniors and people with disabilities covered by Medicare and people with private insurance coverage. H.R. 3 holds drug corporations accountable for price-gouging patients in order to inflate their profits,
By BEN JEALOUS
If enacted, H.R. 3, the Elijah E. Cummings Lower Drug Prices Now Act, would, for the first time, give the government the power to negotiate lower drug prices for millions of patients enrolled in Medicare, and millions more with private insurance. The stakes are huge: Not only would this save Medicare $500 billion over the next decade, these savings would be used to expand benefits to include dental,
By ROBIN TANNER
My mother is one of the 7.4 million Americans who depend on insulin to manage their diabetes.
With insulin prices nearly doubling from 2012 to 2016, my family and millions of others have been forced to cut corners to afford their life-saving medication, all while drug corporations have raked in billions in profits, including two companies based right here in our state.
BY SARA EWING-MERRILLSPECIAL TO THE PRESS HERALD
People who take insulin are among those hardest hit by spiraling expenses. A new medication pricing bill would help them.
Americans agree that prescription drug prices are too high. Countless individuals and families across the country are grappling with impossible choices between buying the medication they need to stay healthy and paying the bills. And with no prescription is that truer than insulin.
BY MITCH LENETT
Amid the ongoing health care debate in Washington, the House of Representatives will soon consider game-changing legislation that would provide relief to the American public from the high costs of prescription drugs.
BY MARTY HENDERSON, PATRICK CAROLAN
In the United States, 30.3 million people live with diabetes. One in four of those people — about 7.5 million people — is forced to ration insulin because of the high price of this life-saving drug. Proverbs 15:27 tells us: “He who is greedy for gain troubles his own house.”
No one should die because they have been priced out of purchasing a lifesaving medicine that costs no more than $6.16 to produce.
By BENJAMIN DUONG AND LORRAINE TULIANO
As people age, they need more prescription drugs to address chronic and age-related health issues at a time when their household income and resources are declining. This issue is especially critical in Florida, which leads the nation in aging seniors, with 20% of the population being 65 or older as of 2017. With no limit on out-of-pocket costs for Medicare drugs, millions of seniors are struggling,
BY JENNIFER BUTLER
As a pastor, I am deeply invested in the health and well being of my community. Every day, I pray for God to heal those who are sick, and to move our elected leaders to pass policies that end needless suffering.
In the Christian Bible, the Book of James teaches that faith without works is dead. Our religion exhorts us to take meaningful steps to heal the world even as we rely on God’s grace for our ultimate salvation.
BY MARGARIDA JORGE
Prescription opioid overdoses have claimed more than 200,000 lives in the United States over the last decade, ravaging countless towns and cities and emerging as a case study for some of the worst corporate abuse in years.
BY MARGARIDA JORGE
This week, the Trump administration announced plans to allow Americans to access lower-cost prescription drugs from Canada at some point in the future. Although importing cheaper drugs is a step in the right direction, it does nothing to solve the crisis that millions of Americans struggling to afford the prescription medicine are facing right now.